Abintus Bio
PrivateLast Round
Series B
Aug 15, 2022
Total Funding Raised
$15.65M
Company Overview
Abintus Bio is a biotechnology company that develops in vivo genetic medicines designed to reprogram a patient's immune cells directly within the body.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abintus Bio Comparables
Compare Abintus Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alaya.bio | 87% | |
| Eli Lilly and Company | 83% | |
| Umoja Biopharma | 78% | |
Abintus Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 15, 2022 | ||||
| Seed | Apr 22, 2021 |
Key People
Founding team and executive leadership
Abintus Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Skyviews Life Science | Series B |
| Tech Coast Angels | Series B |
| Leukemia & Lymphoma Society | Series B |
| SeedFolio | Series B |
| BioBrit | Series B |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Seed |
| Takeda Ventures | Seed, Series B |
Abintus Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abintus Bio's valuation, stock price, and market status.